Properties
Description
Paprotrain is designed to block the activity of dual-specificity tyrosine-regulated kinase (DYRK), which are involved in various cellular processes including cell differentiation and survival. It targets MKLP-2.
Molecular Formula
C16H11N3
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Paprotrain can be used to inhibit the mitotic kinesin Eg5, studied in cancer research.